Logo image of MDX.CA

MEDX HEALTH CORP (MDX.CA) Stock Fundamental Analysis

TSX-V:MDX - TSX Venture Exchange - CA5850901037 - Common Stock - Currency: CAD

0.065  0 (0%)

Fundamental Rating

0

Overall MDX gets a fundamental rating of 0 out of 10. We evaluated MDX against 15 industry peers in the Health Care Equipment & Supplies industry. MDX may be in some trouble as it scores bad on both profitability and health. MDX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MDX has reported negative net income.
In the past year MDX has reported a negative cash flow from operations.
MDX had negative earnings in each of the past 5 years.
In the past 5 years MDX always reported negative operating cash flow.
MDX.CA Yearly Net Income VS EBIT VS OCF VS FCFMDX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -1M -2M -3M -4M -5M

1.2 Ratios

With a Return On Assets value of -447.65%, MDX is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -447.65%
ROE N/A
ROIC N/A
ROA(3y)-702.4%
ROA(5y)-658.9%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MDX.CA Yearly ROA, ROE, ROICMDX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 -400 -600

1.3 Margins

MDX has a Gross Margin of 39.80%. This is comparable to the rest of the industry: MDX outperforms 42.86% of its industry peers.
MDX's Gross Margin has declined in the last couple of years.
MDX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.99%
GM growth 5Y-8.48%
MDX.CA Yearly Profit, Operating, Gross MarginsMDX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800 -1K

More info and screens

0

2. Health

2.1 Basic Checks

MDX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MDX has more shares outstanding
Compared to 5 years ago, MDX has more shares outstanding
MDX has a worse debt/assets ratio than last year.
MDX.CA Yearly Shares OutstandingMDX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M
MDX.CA Yearly Total Debt VS Total AssetsMDX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M

2.2 Solvency

MDX has an Altman-Z score of -104.09. This is a bad value and indicates that MDX is not financially healthy and even has some risk of bankruptcy.
MDX's Altman-Z score of -104.09 is on the low side compared to the rest of the industry. MDX is outperformed by 78.57% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -104.09
ROIC/WACCN/A
WACC8.41%
MDX.CA Yearly LT Debt VS Equity VS FCFMDX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M -4M -6M

2.3 Liquidity

MDX has a Current Ratio of 0.10. This is a bad value and indicates that MDX is not financially healthy enough and could expect problems in meeting its short term obligations.
MDX has a worse Current ratio (0.10) than 92.86% of its industry peers.
MDX has a Quick Ratio of 0.10. This is a bad value and indicates that MDX is not financially healthy enough and could expect problems in meeting its short term obligations.
MDX has a worse Quick ratio (0.05) than 92.86% of its industry peers.
Industry RankSector Rank
Current Ratio 0.1
Quick Ratio 0.05
MDX.CA Yearly Current Assets VS Current LiabilitesMDX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

MDX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.72%, which is quite impressive.
MDX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -33.17%.
Measured over the past years, MDX shows a very negative growth in Revenue. The Revenue has been decreasing by -15.95% on average per year.
EPS 1Y (TTM)39.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.33%
Revenue 1Y (TTM)-33.17%
Revenue growth 3Y-4.89%
Revenue growth 5Y-15.95%
Sales Q2Q%-54.61%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MDX.CA Yearly Revenue VS EstimatesMDX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
MDX.CA Yearly EPS VS EstimatesMDX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 -0 -0 -0.01 -0.01 -0.01

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MDX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDX.CA Price Earnings VS Forward Price EarningsMDX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MDX.CA Per share dataMDX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.01 -0.02 -0.03

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MDX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MEDX HEALTH CORP

TSX-V:MDX (3/7/2025, 7:00:00 PM)

0.065

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-26 2024-11-26/amc
Earnings (Next)05-28 2025-05-28
Inst Owners0.01%
Inst Owner ChangeN/A
Ins Owners29.5%
Ins Owner ChangeN/A
Market Cap17.70M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 45.54
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS-0.03
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -447.65%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.8%
FCFM N/A
ROA(3y)-702.4%
ROA(5y)-658.9%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.99%
GM growth 5Y-8.48%
F-Score3
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.1
Quick Ratio 0.05
Altman-Z -104.09
F-Score3
WACC8.41%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-33.17%
Revenue growth 3Y-4.89%
Revenue growth 5Y-15.95%
Sales Q2Q%-54.61%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y16.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.04%
OCF growth 3YN/A
OCF growth 5YN/A